User menu

Survival in patients with neuroendocrine tumors after treatment with [Y-90-DOTA,Tyr(3)]octreotide in a phase-1 study.

Bibliographic reference Valkema, R ; Pauwels, Stanislas ; Jamar, François ; Kvols, L ; Smith, C ; et. al. Survival in patients with neuroendocrine tumors after treatment with [Y-90-DOTA,Tyr(3)]octreotide in a phase-1 study..50th Annual Meeting of the Society-of-Nuclear-Medicine (NEW ORLEANS (Louisiana), Jun 21-25, 2003). In: The Journal of Nuclear Medicine, Vol. 44, no. 5, p. 136P-136P (2003)
Permanent URL http://hdl.handle.net/2078.1/61471